Cisen Pharmaceutical Co Ltd (603367) — Cash Flow-to-Debt Ratio
Cisen Pharmaceutical Co Ltd (603367) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2025, meaning its operating cash flow of CN¥311.93 Million could theoretically repay 0% of its total liabilities (CN¥1.43 Billion) in one year. See 603367 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cisen Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Cisen Pharmaceutical Co Ltd across 14 annual periods. Also explore Cisen Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cisen Pharmaceutical Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Cisen Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Cisen Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.36x | CN¥570.85 Million | CN¥1.57 Billion | ▲ +26.9% |
| 2023 | 0.29x | CN¥451.24 Million | CN¥1.57 Billion | ▲ +62.2% |
| 2022 | 0.18x | CN¥258.35 Million | CN¥1.46 Billion | ▼ -0.9% |
| 2021 | 0.18x | CN¥233.60 Million | CN¥1.31 Billion | ▼ -43.5% |
| 2020 | 0.32x | CN¥431.01 Million | CN¥1.36 Billion | ▲ +67.4% |
| 2019 | 0.19x | CN¥181.26 Million | CN¥959.97 Million | ▼ -49.2% |
| 2018 | 0.37x | CN¥406.68 Million | CN¥1.09 Billion | ▼ -13.9% |
| 2017 | 0.43x | CN¥439.61 Million | CN¥1.02 Billion | ▲ +45.3% |
| 2016 | 0.30x | CN¥291.97 Million | CN¥982.26 Million | ▲ +4.4% |
| 2015 | 0.28x | CN¥266.24 Million | CN¥935.33 Million | ▲ +719.1% |
| 2014 | 0.03x | CN¥27.54 Million | CN¥792.44 Million | ▼ -72.8% |
| 2013 | 0.13x | CN¥81.26 Million | CN¥636.48 Million | ▲ +81.4% |
| 2012 | 0.07x | CN¥33.09 Million | CN¥470.06 Million | ▼ -78.8% |
| 2011 | 0.33x | CN¥76.28 Million | CN¥230.02 Million | — |